-
Mashup Score: 0Survey Finds Slow Start on CMS Interoperability Rule Implementation - 16 hour(s) ago
With deadlines looming in 2026 and 2027 for compliance with the CMS Advancing Interoperability and Improving Prior Authorization Final Rule, a survey indicates a concerning lack of readiness among payers and providers to meet the new requirements for data sharing.
Source: www.ajmc.comCategories: General Medicine NewsTweet
-
Mashup Score: 0
As Medicare Advantage (MA) enrollment grows, Johnie Rose, MD, PhD, Case Western Reserve University School of Medicine, underscores the importance of ongoing research into outcomes for MA beneficiaries vs fee-for-service (FFS) Medicare beneficiaries.
Source: www.ajmc.comCategories: General Medicine NewsTweet-
As #MedicareAdvantage (MA) enrollment grows, Dr Johnie Rose of @cwru School of Medicine underscores the importance of ongoing research into outcomes for MA beneficiaries vs fee-for-service #Medicare beneficiaries. Watch here: https://t.co/ZCjOOFlawW https://t.co/iVZaMvW0L6
-
-
Mashup Score: 1National Data Show Rising Risk, Cost of CKD in Patients With Acute Myocardial Infarction - 2 day(s) ago
A series of new studies from the National Kidney Foundation Spring Clinical Meeting exhibit the association between impaired kidney function and prolonged hospital stays, higher charges, and greater resource utilization.
Source: www.ajmc.comCategories: General Medicine NewsTweet-
A series of new studies from the National Kidney Foundation Spring Clinical Meeting / @@NKF_NephPros exhibit the association between impaired #kidneyfunction and prolonged hospital stays, higher charges, and greater resource utilization: https://t.co/ncPdQwQYfk
-
-
Mashup Score: 0Management of Recurrent C Difficile Infections in the Future - 2 day(s) ago
Paul Feuerstadt, MD, FACG, AGAF, discusses how the management of recurrent Clostridioides difficile infections is evolving toward more targeted approaches, including microbiome-based therapies like fecal microbiota transplantation, newer antibiotics such as fidaxomicin, and emerging preventive strategies focusing on microbiome restoration and preservation.
Source: www.ajmc.comCategories: General Medicine NewsTweet-
Learn about the future of Clostridioides difficile care. Paul Feuerstadt, MD, FACG, AGAF, discusses microbiome-based therapies, advanced antibiotics, and evolving strategies. Learn what’s next: https://t.co/H9RKFEuefI
-
-
Mashup Score: 0
Several court cases have been filed against the Trump administration over disruptions touching health care, including funding cuts and employee layoffs.
Source: www.ajmc.comCategories: General Medicine NewsTweet-
Several court cases have been filed against the Trump administration over disruptions touching health care, including #fundingcuts and employee #layoffs. Here are 5 key takeaways: https://t.co/WJrAe5wuHf
-
-
Mashup Score: 0Empowering Nonspecialist Providers and Addressing Gaps in Dementia Care: How Tools and Biomarkers Can Help - 3 day(s) ago
Panelists discuss how significant knowledge gaps among nonspecialist providers—particularly regarding differential diagnosis, interpretation of cognitive assessments, and awareness of treatment options—are being addressed through targeted educational initiatives, embedded clinical decision support tools, and collaborative care models to enhance understanding of early Alzheimer diagnosis and treatment importance.
Source: www.ajmc.comCategories: General Medicine NewsTweet-
How can knowledge gaps be addressed to improve early #AlzheimerDiagnosis? Experts discuss the value of targeted educational initiatives, embedded clinical decision support tools, and collaborative care models. Watch Here: https://t.co/5FrzPMhba4 #ManagedCare
-
-
Mashup Score: 0
Adam Colborn, JD, associate vice president for congressional affairs, Academy of Managed Care Pharmacy, highlights key policy updates that are impacting managed care pharmacy.
Source: www.ajmc.comCategories: General Medicine NewsTweet-
Adam Colborn, JD, associate vice president for congressional affairs, Academy of Managed Care Pharmacy / @amcporg highlights key policy updates that are impacting #managedcare pharmacy. Watch now: https://t.co/uh6cGTvH0d
-
-
Mashup Score: 0
Researchers warned that to achieve such reductions, greater uptake of the medication among indicated patients is needed.
Source: www.ajmc.comCategories: General Medicine NewsTweet-
#semaglutide could prevent up to 2 million major adverse #cardiovascular events and over 1 million deaths, according to a new modeling study. Learn more: https://t.co/IjXfVLg5hg
-
-
Mashup Score: 0How the Genetic Nature of Lp(a) Levels Influences Screening - 4 day(s) ago
Experts discuss the genetic determinants of lipoprotein(a) (Lp[a]) levels, providing evidence supporting this conclusion. They also explore how the hereditary nature of Lp(a) can drive awareness of atherosclerotic cardiovascular disease (ASCVD) and aortic stenosis risk, potentially influencing screening protocols.
Source: www.ajmc.comCategories: General Medicine NewsTweet-
Experts discuss the genetic basis of #lipoprotein(a) and how its hereditary nature impacts ASCVD and aortic stenosis risk. Insights from this could influence future screening protocols and improve patient outcomes. Watch the episode https://t.co/i5RXefgRuj #cardiovascularhealth
-
-
Mashup Score: 2
Long-term extension analysis of the phase 3b APEX study (NCT04882098) through 3 years of treatment will further assess the sustained efficacy of guselkumab (Tremfya; Johnson & Johnson) in limiting structural damage in patients with active psoriatic arthritis (PsA).
Source: www.ajmc.comCategories: General Medicine NewsTweet-
The phase 3b APEX study confirmed that #guselkumab (#Tremfya; @JNJNews) reduces signs and symptoms of disease and structural damage progression in adults living with active psoriatic arthritis. Learn more here: https://t.co/3yiDVCnR5l https://t.co/p2VKZY6dbx
-
As deadlines loom for compliance with the @CMSGov Advancing Interoperability and Improving Prior Authorization Final Rule, this survey shows a concerning lack of readiness among #payers and #providers to meet the new data sharing requirements. Learn more: https://t.co/llFb45GRgV https://t.co/ktBkA8vPvM